NCCN Staff Honored with Awards for Cancer Care Equity, Research, and Patient Education
Event summary
- Alyssa Schatz, NCCN's Vice President of Policy and Advocacy, received the Leadership in Policy, Equity, and Advocacy award from the National Minority Quality Forum.
- Faviolla Baez-Cruz, NCCN's Associate Scientist/Medical Writer, was named a 2026 Journal of Biological Chemistry awardee for her research on beta-cardiac myosin.
- NCCN's Guidelines for Patients: Bone Cancer won a Gold Hermes Creative Award for excellence in publications and informational materials.
- NCCN's Guidelines for Patients: Liver Cancer is a finalist for the 2026 ClearMark Award from the Center for Plain Language.
The big picture
NCCN's recent awards and publications underscore its commitment to advancing cancer care through equity, research, and patient education. The recognition from independent organizations highlights the organization's role in defining and promoting quality, effective, and accessible cancer care. These achievements position NCCN as a leader in the healthcare sector, particularly in addressing disparities in cancer treatment and improving patient outcomes.
What we're watching
- Equity Initiatives
- How NCCN's Health Equity Report Card (HERC) will impact community-based cancer care practices and whether it can sustain engagement and refinement.
- Research Impact
- The pace at which NCCN's involvement in biochemical research will translate into clinical applications and improve cancer treatment outcomes.
- Patient Education
- Whether NCCN's annual updates to patient guidelines in English and Spanish will enhance patient empowerment and informed decision-making.
Related topics